User profiles for "author:Eric Devor"
Eric J DevorResearch Assistant Professor, OB/GYN, University of Iowa Carver College of Medicine Verified email at uiowa.edu Cited by 4818 |
Genetics of alcoholism
EJ Devor, CR Cloninger - Annual Review of Genetics, 1989 - annualreviews.org
The genetics of alcoholism is at a pivotal point in its history. Decades of study of alcoholics,
their families, and controls have revealed an increasingly sophisticated clinical picture in …
their families, and controls have revealed an increasingly sophisticated clinical picture in …
Nanoparticle-based delivery of CRISPR/Cas9 genome-editing therapeutics
The recent progress in harnessing the efficient and precise method of DNA editing provided
by CRISPR/Cas9 is one of the most promising major advances in the field of gene therapy …
by CRISPR/Cas9 is one of the most promising major advances in the field of gene therapy …
Genetics of aggressive and violent behavior
Aggressive behavior has been defined in numerous ways to include behaviors ranging from
the milder forms of aggression such as throwing a temper tantrum or pouting to the more …
the milder forms of aggression such as throwing a temper tantrum or pouting to the more …
[HTML][HTML] MicroRNA expression in the human blastocyst
EM Rosenbluth, DN Shelton, AET Sparks, E Devor… - Fertility and sterility, 2013 - Elsevier
OBJECTIVE: To determine the most highly expressed microRNAs (miRNAs) in human
blastocysts and to compare miRNAs in euploid versus aneuploid embryos and in male …
blastocysts and to compare miRNAs in euploid versus aneuploid embryos and in male …
Alcoholism and alleles of the human D2 dopamine receptor locus: studies of association and linkage
A Parsian, RD Todd, EJ Devor… - Archives of general …, 1991 - jamanetwork.com
• The association of the A1 allele of the D 2 dopamine receptor gene with alcoholism was
examined by comparing 32 unrelated white alcoholics with 25 unrelated white controls and …
examined by comparing 32 unrelated white alcoholics with 25 unrelated white controls and …
Transmission of human craniofacial dimensions.
EJ Devor - Journal of craniofacial genetics and developmental …, 1987 - europepmc.org
The transmissibilities of 11 human craniofacial dimensions are estimated by path analysis
based upon familial correlations obtained in four different populations. Estimates from both …
based upon familial correlations obtained in four different populations. Estimates from both …
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG …
KW Thiel, EJ Devor, VL Filiaci, D Mutch… - Journal of clinical …, 2022 - ascopubs.org
PURPOSE The status of p53 in a tumor can be inferred by next-generation sequencing
(NGS) or by immunohistochemistry (IHC). We examined the association between p53 IHC …
(NGS) or by immunohistochemistry (IHC). We examined the association between p53 IHC …
Pregnant mice lacking indoleamine 2, 3‐dioxygenase exhibit preeclampsia phenotypes
MK Santillan, CJ Pelham… - Physiological …, 2015 - Wiley Online Library
Preeclampsia is a cardiovascular disorder of late pregnancy that is, commonly characterized
by hypertension, renal structural damage and dysfunction, and fetal growth restriction …
by hypertension, renal structural damage and dysfunction, and fetal growth restriction …
[HTML][HTML] TP53 oncomorphic mutations predict resistance to platinum‑and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian …
P Brachova, SR Mueting… - international …, 2015 - spandidos-publications.com
Individual mutations in the tumor suppressor TP53 alter p53 protein function. Some
mutations create a non‑functional protein, whereas others confer oncogenic activity, which …
mutations create a non‑functional protein, whereas others confer oncogenic activity, which …
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology …
KK Leslie, VL Filiaci, AR Mallen, KW Thiel, EJ Devor… - Gynecologic …, 2021 - Elsevier
Background Successfully combining targeted agents with chemotherapy is an important
future goal for cancer therapy. However, an improvement in patient outcomes requires an …
future goal for cancer therapy. However, an improvement in patient outcomes requires an …